SNP Genotyping Assay: Technical Principles, Methods, and Applications

SNP genotyping assay is a molecular diagnostic technique that identifies single nucleotide polymorphisms—the most abundant form of genetic variation—in DNA samples with high accuracy and throughput. This comprehensive technical guide covers the principles of SNP detection, sample requirements, mainstream testing platforms, and applications spanning clinical diagnostics, pharmacogenomics, and agricultural molecular breeding.

Technical Overview

Single nucleotide polymorphisms (SNPs) are variations at a single base position in the genome that occur in more than 1% of a population. With an estimated 10 million SNPs present across the human genome, these markers serve as the foundation for modern genetics research, precision medicine, and molecular breeding programs. SNP genotyping detection refers to the laboratory process of determining which nucleotide variant (allele) an individual carries at a specific genomic position.

A typical SNP genotyping workflow comprises four core stages: genomic DNA extraction and quality control, target locus amplification, allele discrimination, and data analysis. Depending on the platform, allele discrimination is achieved through fluorescence hybridization probes, mass spectrometry, sequencing chemistry, or melting curve analysis. Modern SNP genotyping platforms achieve call rates above 98% and accuracy above 99.9%, enabling reliable interpretation in both clinical and research settings.

The selection of a genotyping strategy depends primarily on the number of SNP targets, sample throughput, required sensitivity, and downstream application. From single-marker assays for diagnostic confirmation to genome-wide arrays containing hundreds of thousands of markers, scalable solutions are available for projects of every size.

Testing Samples

Human Clinical Samples

Peripheral blood collected in EDTA anticoagulant tubes is the preferred sample type for human SNP genotyping, typically requiring 0.5–2 mL per submission. Buccal swabs and saliva samples provide non-invasive alternatives suitable for large-scale population screening and direct-to-consumer testing. Fresh-frozen or FFPE tissue sections may also be accepted for retrospective studies.

Animal Samples

Livestock and companion animal genotyping commonly uses ear notch tissue, tail or hair follicle samples (with roots intact), blood spots on FTA cards, and semen straws. These sample types support parentage verification, breed identification, and marker-assisted selection breeding programs.

Plant Samples

Young, healthy leaf tissue harvested during the active growth stage yields the highest quality DNA for plant genotyping. Samples should be collected in self-sealing bags with silica gel desiccant or shipped frozen on dry ice. Seeds, root tips, and callus tissue can also be processed when leaf material is unavailable.

Purified Genomic DNA

Pre-extracted genomic DNA is accepted provided it meets minimum quality thresholds: concentration ≥20 ng/µL, total yield ≥500 ng, A260/A280 ratio between 1.8 and 2.0, and no visible degradation on agarose gel electrophoresis. DNA samples should be transported on dry ice or with cold packs to preserve integrity.

Testing Items

SNP genotyping services are organized into configurable project categories based on target scale and research objective:

• Single SNP genotyping: candidate locus validation, diagnostic confirmation of known pathogenic variants, and quality control checks for individual markers.

• Small to mid-scale SNP panels: custom panels of 10 to 500 markers for pharmacogenomics, disease risk profiling, and molecular breeding selection.

• Large-scale genotyping arrays: standardized SNP microarrays containing 50,000 to 800,000+ markers for genome-wide association studies (GWAS) and population structure analysis.

• Targeted region sequencing panels: comprehensive variant discovery and genotyping across candidate genes or regulatory regions.

• Custom assay development: design, optimization, and validation of de novo assays for novel or rare SNPs not covered by commercial platforms.

Testing Methods

TaqMan Probe-Based qPCR

This gold-standard method employs two allele-specific fluorescent probes, each labeled with a distinct reporter dye (FAM or VIC). During amplification, only the probe perfectly matched to the target allele is cleaved, generating genotype-specific fluorescence signals. Results are visualized as three distinct clusters on an allelic discrimination plot representing homozygous and heterozygous genotypes. The method delivers excellent sensitivity, requires minimal DNA input, and is ideal for fewer than 100 targets.

KASP Genotyping

Kompetitive Allele-Specific PCR (KASP) uses competitive allele-specific primers combined with a universal fluorescent resonance energy transfer (FRET) reporter cassette. It offers a cost-effective solution for mid-throughput agricultural genotyping, supporting marker-assisted selection and QTL validation in crops and livestock.

Sanger Sequencing

Direct sequencing of PCR amplicons provides unambiguous genotype confirmation across the entire amplified region, capturing both targeted SNPs and neighboring variants. It remains the reference method for validating novel genotypes identified by other platforms.

MassARRAY Mass Spectrometry

The MassARRAY platform combines multiplex PCR with MALDI-TOF mass spectrometry detection of extension products. It balances throughput and cost effectively for panels of 20 to several hundred SNPs, achieving multiplexing of up to 40 markers per reaction.

SNP Microarray

Next-Generation Sequencing

High-density SNP chips enable simultaneous interrogation of hundreds of thousands to millions of fixed markers, powering GWAS, ancestry analysis, and copy-number studies. Targeted NGS approaches, including amplicon-based and hybrid capture panels, provide flexible genotyping with added capability to detect low-frequency variants in mixed samples.

PCR-RFLP and HRM Analysis

Classic polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP) distinguishes alleles through restriction enzyme digestion patterns, while high-resolution melting (HRM) analysis differentiates genotypes by amplicon melting behavior. Both remain economical options for well-characterized markers in resource-limited laboratories.

Applications

SNP genotyping detection supports a broad spectrum of clinical, research, and industrial applications:

• Clinical diagnostics: carrier screening for inherited disorders, pharmacogenomic profiling of drug metabolism genes such as CYP2C19 and CYP2D6, and risk stratification for complex diseases including cardiovascular disease and diabetes.

• Oncology support: genotyping of germline susceptibility variants and validation of somatic mutations detected during tumor molecular profiling.

• Reproductive genetics: preimplantation genetic testing for monogenic disease (PGT-M), prenatal carrier assessment, and newborn screening programs.

• Forensic and identity testing: individual identification, paternity and kinship verification, and ancestry inference.

• Agricultural molecular breeding: marker-assisted selection (MAS), genomic selection, variety purity testing, and trait-linked marker validation in crops, livestock, and aquatic species.

• Basic research: GWAS, population genetics, linkage analysis, evolutionary biology, and genome diversity studies in model and non-model organisms.

FAQ

How much DNA is required for SNP genotyping?

Input requirements vary by platform. TaqMan assays typically require 5–20 ng of DNA per reaction, KASP assays need approximately 10–50 ng, microarray platforms require 200–500 ng, and sequencing-based methods generally call for at least 100 ng of high-quality genomic DNA. Samples below these thresholds can often be rescued through whole-genome amplification.

What accuracy can be expected from SNP genotyping results?

Established platforms deliver genotype accuracy exceeding 99.5%, with TaqMan qPCR and microarray approaches routinely exceeding 99.9%. Each project includes positive control samples, negative controls, and duplicate testing where appropriate to guarantee reproducibility.

Can degraded DNA samples from FFPE blocks be genotyped?

Yes. Short amplicon-based methods such as TaqMan qPCR and targeted NGS are specifically optimized for fragmented FFPE-derived DNA, provided that amplifiable fragments of 80–150 base pairs remain intact.

What is the typical turnaround time?

Single-plex and low-plex assays are generally completed within 5–10 business days after sample and primer or probe confirmation. Large-scale array or sequencing projects typically require 2–4 weeks depending on sample volume and data analysis complexity.

Is technical support available for assay design and data interpretation?

Comprehensive support covers SNP marker selection, primer and probe design, panel configuration, statistical analysis of genotype data, and preparation of publication-ready figures. Custom bioinformatics pipelines are available for association studies and genomic selection modeling.